Prevalence and Phenotypic Effects of Copy Number Variants in Isolated Hypogonadotropic Hypogonadism.

CONTEXT: The genetic architecture of Isolated Hypogonadotropic Hypogonadism (IHH) has not been completely defined.

OBJECTIVE: To determine the role of copy number variants (CNVs) in IHH pathogenicity and define their phenotypic spectrum.

DESIGN: Exome sequencing (ES) data in IHH probands and family members was analyzed for CNVs and single nucleotide variants (SNVs)/indels in 62 known IHH genes. IHH subjects without SNVs/indels in known genes were considered "unsolved". Phenotypes associated with CNVs were evaluated through review of patient medical records.

SETTING: The Reproductive Endocrine Unit and the Center for Genomic Medicine of Massachusetts General Hospital.

PATIENTS OR OTHER PARTICIPANTS: IHH probands [n=1,394: Kallmann Syndrome (KS): IHH with anosmia (n=706); normosmic IHH (nIHH) (n=688] and their family members (n= 1092).

INTERVENTIONS/MAIN OUTCOME RESULTS: A total of 29 CNVs in 13 genes were detected (overall IHH cohort prevalence: ~2%). Almost all (28/29) CNVs occurred in unsolved IHH cases. While some genes (e.g., ANOS1 and FGFR1) frequently harbor both CNVs and SNVs/indels, the mutational spectrum of others (e.g., CHD7) was restricted to SNVs/indels. Syndromic phenotypes were seen in 83% and 63% of IHH subjects with multigenic and single gene CNVs, respectively.

CONCLUSIONS: CNVs in known genes contribute to ~2% of IHH pathogenesis. Predictably, multigenic contiguous CNVs resulted in syndromic phenotypes. Syndromic phenotypes resulting from single gene CNVs validate pleiotropy of some IHH genes. Genome sequencing approaches are now needed to identify novel genes and/or other elusive variants (e.g., non-coding/complex structural variants) that may explain the remaining missing etiology of IHH.